Ethyl Glucuronide in Urine Samples of Pregnant Women Within the HUS ja PHHYKY Area
NCT ID: NCT04571463
Last Updated: 2022-11-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
505 participants
OBSERVATIONAL
2020-10-01
2021-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Alcohol Use During Pregnancy in Finland According to Meconium Samples
NCT04918043
Measuring hCG Levels in Pregnant Women
NCT02763176
Clearblue Pregnancy Test - Lay User Study
NCT04043169
Hyperemesis Gravidarum and 75 Gram Oral Glucose Tolerance Test
NCT02963753
Clearblue Pregnancy Test Lay User Usage Study
NCT04746014
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HUCS A
Mothers visiting the prenatal care units within the Helsinki area.
No interventions assigned to this group
HUCS HAL
Mothers visiting the prenatal care units dedicated for the alcohol and drug abusing mothers within the Helsinki area.
No interventions assigned to this group
PHHYKY A
Mothers visiting the prenatal care units within the Lahti area.
No interventions assigned to this group
PHHYKY HALSO
Mothers visiting the prenatal care units dedicated for the alcohol and drug abusing mothers within the Lahti area.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Finnish Pediatric Neurology Association
UNKNOWN
Finnish Foundation for Alcohol Studies
OTHER
Päijänne Tavastia Central Hospital
OTHER
Helsinki University Central Hospital
OTHER
Seinajoki Central Hospital
OTHER
Hanna Kahila
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hanna Kahila
Senior Ward Physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hanna Kahila, MD
Role: PRINCIPAL_INVESTIGATOR
HUCS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
HALSO-poliklinikka
Lahti, Paijat-Hame Region, Finland
Äitiyspoliklinikka/neuvola
Lahti, Paijat-Hame Region, Finland
HAL-poliklinikka
Helsinki, Uusimaa, Finland
Äitiyspoliklinikka/neuvola
Helsinki, Uusimaa, Finland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Jolma M, Koivu-Jolma M, Niemela O, Autti-Ramo I, Kahila H. Rapid urine screening for ethyl glucuronide from pregnant women as a tool for detecting prenatal alcohol exposure. BMC Pregnancy Childbirth. 2023 Jun 22;23(1):464. doi: 10.1186/s12884-023-05789-x.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HUS/483/2020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.